Pharmacists are warning that the booming demand for weight loss jabs may be unsustainable, with many more people interested in using them than are clinically suitable. The National Pharmacy Association (NPA), representing over 6,000 independent community pharmacies, commissioned a poll of 2,002 people that found 21% had attempted to access weight loss treatments in the past year, rising to 35% among 16 to 34-year-olds.
The poll also revealed that 41% of respondents would opt for NHS weight loss treatments if available, increasing to 64% among 25 to 34-year-olds, despite many being unlikely to meet clinical eligibility criteria. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand highlights the need to ensure this is appropriate for those who want it.'
Spiralling demand, partly fuelled by social media, could drive people to unregulated online suppliers rather than regulated pharmacies, the NPA fears. Online suppliers may not offer weight loss jabs alongside structured behavioural change programmes. Drugs such as Wegovy and Mounjaro are licensed by the MHRA for patients with a BMI over 30, or between 27 and 30 with a weight-related comorbidity.
The NPA is calling for new regulations to protect patients buying weight loss medication online, requiring full two-way consultations and review of medical records before prescribing. They await details on pharmacies' role in the NHS weight management programme. Picard added: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice.'
